Champions Oncology, Inc. (CSBR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 20.18M | 21.33M | 21.01M | 22.37M | 19.7M | 14.08M | 13.18M | 13.64M | 13.2M | 14.02M | 14.92M | 19.46M |
| Cash & Short-Term Investments | 7.13M | 8.52M | 10.32M | 9.79M | 3.2M | 2.75M | 2.89M | 2.62M | 4.47M | 5.51M | 4.87M | 10.12M |
| Cash Only | 7.13M | 8.52M | 10.32M | 9.79M | 3.2M | 2.75M | 2.89M | 2.62M | 4.47M | 5.51M | 4.87M | 10.12M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 12.07M | 11.54M | 9.47M | 11.23M | 15.78M | 10.47M | 9.03M | 9.53M | 7.89M | 7.72M | 8.95M | 8.01M |
| Days Sales Outstanding | - | 280.13 | 247.09 | 331.88 | 338.07 | 283.31 | 234.46 | 248.34 | 239.76 | 243.61 | 260.01 | 223.7 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 991K | 1.28M | 1.22M | 1.35M | 713K | 860K | 1.25M | 1.5M | 835K | 780K | 1.1M | 1.33M |
| Total Non-Current Assets | 8.26M | 8.83M | 9.53M | 9.97M | 10.93M | 11.16M | 11.76M | 12.49M | 13.59M | 14.28M | 14.98M | 14.85M |
| Property, Plant & Equipment | 9.26M | 8.3M | 9M | 9.46M | 10.41M | 10.64M | 11.23M | 11.97M | 13.07M | 13.76M | 14.46M | 14.5M |
| Fixed Asset Turnover | - | 1.81x | 1.55x | 1.31x | 1.64x | 1.27x | 1.25x | 1.17x | 0.92x | 0.84x | 0.87x | 0.90x |
| Goodwill | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K | 335K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | -1.33M | 196K | 196K | 185K | 185K | 185K | 185K | 185K | 185K | 185K | 184K | 15K |
| Total Assets | 28.45M | 30.16M | 30.55M | 32.34M | 30.63M | 25.24M | 24.93M | 26.13M | 26.79M | 28.29M | 29.91M | 34.31M |
| Asset Turnover | - | 0.50x | 0.46x | 0.38x | 0.56x | 0.53x | 0.56x | 0.54x | 0.45x | 0.41x | 0.42x | 0.38x |
| Asset Growth % | -7.12% | 19.5% | 22.51% | 23.77% | 14.34% | -10.79% | -16.63% | -23.84% | -25.9% | -22.19% | -13.04% | -3.02% |
| Total Current Liabilities | 20.68M | 22.14M | 22.7M | 23.85M | 19.87M | 18.86M | 19.16M | 21.54M | 21.97M | 20.95M | 20.38M | 21.73M |
| Accounts Payable | 0 | 5.99M | 4.84M | 4.25M | 5.09M | 4.85M | 5.24M | 5.8M | 4.76M | 4.54M | 5.76M | 5.33M |
| Days Payables Outstanding | - | 287.1 | 211.71 | 202.29 | 265 | 226.36 | 254.06 | 292 | 221.17 | 250.17 | 273.56 | 265.32 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 10M | 12.34M | 14.43M | 15.44M | 10.92M | 10.22M | 10.31M | 12.09M | 13.33M | 12.97M | 11.14M | 12.78M |
| Other Current Liabilities | 10.68M | 97K | 116K | 135K | 154K | 151K | 151K | 150K | 149K | 148K | 146K | 145K |
| Current Ratio | 0.98x | 0.96x | 0.93x | 0.94x | 0.99x | 0.75x | 0.69x | 0.63x | 0.60x | 0.67x | 0.73x | 0.90x |
| Quick Ratio | 0.98x | 0.96x | 0.93x | 0.94x | 0.99x | 0.75x | 0.69x | 0.63x | 0.60x | 0.67x | 0.73x | 0.90x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.39M | 3.79M | 4.31M | 4.72M | 5.29M | 5.7M | 6.1M | 6.49M | 6.88M | 7.25M | 7.62M | 7.94M |
| Long-Term Debt | 3.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 3.74M | 4.24M | 4.63M | 5M | 5.37M | 5.74M | 6.09M | 6.44M | 6.78M | 7.11M | 7.39M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 27K | 46K | 66K | 85K | 285K | 324K | 363K | 401K | 439K | 476K | 514K | 551K |
| Total Liabilities | 24.07M | 25.93M | 27.01M | 28.57M | 25.16M | 24.56M | 25.27M | 28.04M | 28.84M | 28.2M | 28M | 29.68M |
| Total Debt | 3.37M | 5.27M | 5.75M | 6.11M | 6.44M | 6.78M | 7.11M | 7.43M | 7.74M | 8.05M | 8.35M | 8.6M |
| Net Debt | -3.76M | -3.25M | -4.58M | -3.68M | 3.23M | 4.02M | 4.21M | 4.81M | 3.27M | 2.54M | 3.48M | -1.52M |
| Debt / Equity | 0.77x | 1.25x | 1.63x | 1.62x | 1.18x | 9.95x | - | - | - | 86.56x | 4.39x | 1.85x |
| Debt / EBITDA | - | 9.72x | - | - | 1.31x | 5.99x | 4.00x | 11.96x | - | - | - | - |
| Net Debt / EBITDA | - | -5.99x | - | - | 0.66x | 3.56x | 2.37x | 7.75x | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | -2.93x |
| Total Equity | 4.38M | 4.23M | 3.54M | 3.77M | 5.47M | 681K | -332K | -1.9M | -2.06M | 93K | 1.9M | 4.64M |
| Equity Growth % | -19.95% | 521.29% | 1165.66% | 298.21% | 365.74% | 632.26% | -117.45% | -141.05% | -129.13% | -98.99% | -78.82% | -49.03% |
| Book Value per Share | 0.32 | 0.29 | 0.26 | 0.27 | 0.38 | 0.05 | -0.02 | -0.14 | -0.15 | 0.01 | 0.14 | 0.34 |
| Total Shareholders' Equity | 4.28M | 4.17M | 3.51M | 3.77M | 5.47M | 681K | -332K | -1.9M | -2.06M | 93K | 1.9M | 4.64M |
| Common Stock | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K |
| Retained Earnings | -80.4M | -80.12M | -80.36M | -79.89M | -78.06M | -82.55M | -83.28M | -84.59M | -84.48M | -81.95M | -79.88M | -77.32M |
| Treasury Stock | 0 | -708K | -708K | -708K | -708K | -708K | -708K | -708K | -708K | -708K | -676K | -74K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 95K | 61K | 30K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |